Munafa Stock Market Course + Intraday & FNO calls 
Arbutus Biopharma (ABUS) Technical (Analysis) Reports Arbutus Biopharma ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Arbutus Biopharma (ABUS)
Technical Analysis Report for USA stock ABUS Arbutus Biopharma. Dated: 05 Oct 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock ABUS Arbutus Biopharma then click here. or read Experts views on Arbutus Biopharma or Forecast & share price targets of Arbutus Biopharma
Arbutus Biopharma Opened at 4.32 and Closed at: 4.67, which is 4.71% of previous session's close. It moved within a range of 4.09 and 4.80
The session was a Bullish session with an average volume of 4371525, which is -105.59% of previous session's volumes.
- Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.
A Dead cross was found 2 days back on mid term averages
Support for tomorrow is 4.38 and resistance for tomorrow is 5.09
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 4.24, 3.81 resistance for tomorrow's hourly charts is 4.95, 5.23
10 Day SMA for Arbutus Biopharma (ABUS) is 4.76 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Arbutus Biopharma (ABUS) is 4.93 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Arbutus Biopharma (ABUS) is 4.84 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 4.67 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Arbutus Biopharma is 4.53 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Arbutus Biopharma is at 4.93 and 200 DMA is at 4.53, while 50 DMA and 100 DMA are at 4.84 and 4.67 respectively
Arbutus Biopharma (ABUS) moving average of 20 SMA is at 4.93 and 20 EMA is at 4.84
| Date | Closing Price | 20 SMA | 20 EMA |
| 05 Mon Oct | 4.67 | 4.93 | 4.84 |
| 02 Fri Oct | 4.45 | 4.95 | 4.86 |
| 01 Thu Oct | 4.56 | 4.98 | 4.9 |
| 30 Wed Sep | 4.78 | 5.01 | 4.94 |
| 29 Tue Sep | 4.69 | 5.03 | 4.96 |
| 28 Mon Sep | 4.86 | 5.04 | 4.99 |
Arbutus Biopharma (ABUS) moving average of 50 SMA is at 4.84 and 50 EMA is at 4.84
| Date | Closing Price | 50 SMA | 50 EMA |
| 05 Mon Oct | 4.67 | 4.84 | 4.84 |
| 02 Fri Oct | 4.45 | 4.83 | 4.85 |
| 01 Thu Oct | 4.56 | 4.83 | 4.87 |
| 30 Wed Sep | 4.78 | 4.83 | 4.88 |
| 29 Tue Sep | 4.69 | 4.82 | 4.88 |
| 28 Mon Sep | 4.86 | 4.82 | 4.89 |
Arbutus Biopharma (ABUS) moving average of 100 SMA is at 4.67 and 100 EMA is at 4.73
| Date | Closing Price | 100 SMA | 100 EMA |
| 05 Mon Oct | 4.67 | 4.67 | 4.73 |
| 02 Fri Oct | 4.45 | 4.67 | 4.73 |
| 01 Thu Oct | 4.56 | 4.67 | 4.74 |
| 30 Wed Sep | 4.78 | 4.67 | 4.74 |
| 29 Tue Sep | 4.69 | 4.66 | 4.74 |
| 28 Mon Sep | 4.86 | 4.66 | 4.74 |
Arbutus Biopharma (ABUS) moving average of 200 SMA is at 4.53 and 200 EMA is at 4.47
| Date | Closing Price | 200 SMA | 200 EMA |
| 05 Mon Oct | 4.67 | 4.53 | 4.47 |
| 02 Fri Oct | 4.45 | 4.53 | 4.47 |
| 01 Thu Oct | 4.56 | 4.54 | 4.47 |
| 30 Wed Sep | 4.78 | 4.54 | 4.47 |
| 29 Tue Sep | 4.69 | 4.54 | 4.47 |
| 28 Mon Sep | 4.86 | 4.54 | 4.47 |
Perrigo Company has performed better than Arbutus Biopharma in short term. You could have earned much better returns by investing in Perrigo Company, about 8.89% more returns!
Pfizer Inc has performed better than Arbutus Biopharma in short term. You could have earned much better returns by investing in Pfizer Inc, about 8.48% more returns!
Novartis Ag has performed better than Arbutus Biopharma in short term. You could have earned much better returns by investing in Novartis Ag, about 12.2% more returns!
Centene Corporation has performed better than Arbutus Biopharma in short term. You could have earned much better returns by investing in Centene Corporation, about 9.43% more returns!
Vtv Therapeutics has performed better than Arbutus Biopharma in short term. You could have earned much better returns by investing in Vtv Therapeutics, about 2.35% more returns!
Arbutus Biopharma has performed better than Tonix Pharmaceuticals in short term. Holding Arbutus Biopharma could be a better choice for now!
Supernus Pharmaceuticals has performed better than Arbutus Biopharma in short term. You could have earned much better returns by investing in Supernus Pharmaceuticals, about 10.63% more returns!
Arbutus Biopharma has performed better than Sellas Life in short term. Holding Arbutus Biopharma could be a better choice for now!
Natera Inc has performed better than Arbutus Biopharma in short term. You could have earned much better returns by investing in Natera Inc, about 41.17% more returns!
Merit Medical has performed better than Arbutus Biopharma in short term. You could have earned much better returns by investing in Merit Medical, about 9.58% more returns!
Orthopediatrics Corp has performed better than Arbutus Biopharma in short term. You could have earned much better returns by investing in Orthopediatrics Corp, about 12.87% more returns!
Incyte Corporation has performed better than Arbutus Biopharma in short term. You could have earned much better returns by investing in Incyte Corporation, about 1.59% more returns!
Icu Medical has performed better than Arbutus Biopharma in short term. You could have earned much better returns by investing in Icu Medical, about 10.17% more returns!
Arbutus Biopharma has performed better than Cue Biopharma in short term. Holding Arbutus Biopharma could be a better choice for now!
Cumberland Pharmaceuticals has performed better than Arbutus Biopharma in short term. You could have earned much better returns by investing in Cumberland Pharmaceuticals, about 16.95% more returns!
Arbutus Biopharma has performed better than Cooper Companies in short term. Holding Arbutus Biopharma could be a better choice for now!
Caredx Inc has performed better than Arbutus Biopharma in short term. You could have earned much better returns by investing in Caredx Inc, about 48.81% more returns!
Ani Pharmaceuticals has performed better than Arbutus Biopharma in short term. You could have earned much better returns by investing in Ani Pharmaceuticals, about 13.2% more returns!
Arbutus Biopharma has performed better than Akari Therapeutics in short term. Holding Arbutus Biopharma could be a better choice for now!
Arbutus Biopharma Technical analysis of indicators
Price action analysis of Arbutus Biopharma (ABUS) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Arbutus Biopharma stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Arbutus Biopharma in short term and the sell signal is strong.
Arbutus Biopharma Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Arbutus Biopharma in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Arbutus Biopharma is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 4.75 and Arbutus Biopharma ABUS stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Arbutus Biopharma ABUS stock. Volume based technical analysis of Arbutus Biopharma ABUS stock is negative.
Arbutus Biopharma Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock ABUS Arbutus Biopharma These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And ABUS Experts View which covers a lot of information including buying and selling signals
ABUS future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Arbutus Biopharma or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Arbutus Biopharma (ABUS) Technical (Analysis) Reports Arbutus Biopharma ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
